CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Pretreatment neutrophil-to-lymphocyte ratio and its dynamic change during neoadjuvant chemotherapy as poor prognostic factors in advanced ovarian cancer
Yun-Ji Kim, Inha Lee, Young Shin Chung, EunJi Nam, Sunghoon Kim, Sang-Wun Kim, Young Tae Kim, Jung-Yun Lee
Obstet Gynecol Sci. 2018;61(2):227-234.   Published online February 5, 2018
DOI: https://doi.org/10.5468/ogs.2018.61.2.227

Excel Download

Pretreatment neutrophil-to-lymphocyte ratio and its dynamic change during neoadjuvant chemotherapy as poor prognostic factors in advanced ovarian cancer
Obstetrics & Gynecology Science. 2018;61(2):227   Crossref logo
Link1 Link2 Link3

Prognostic Value of the Pretreatment Neutrophil-to-Lymphocyte Ratio in Different Phenotypes of Locally Advanced Breast Cancer During Neoadjuvant Systemic Treatment
Clinical Breast Cancer. 2020;20(4):307-316.e1   Crossref logo
Link1 Link2

Re: Low Pretreatment Neutrophil-to-Lymphocyte Ratio Predicts for Good Outcomes in Patients Receiving Neoadjuvant Chemotherapy Before Radical Cystectomy for Muscle Invasive Bladder Cancer
European Urology. 2017;72(6):1026   Crossref logo
Link1 Link2

Prechemotherapy neutrophil : lymphocyte ratio is superior to the platelet : lymphocyte ratio as a prognostic indicator for locally advanced esophageal squamous cell cancer treated with neoadjuvant chemotherapy
Diseases of the Esophagus. 2015;29(5):403-411   Crossref logo
Link1 Link2

Pretreatment neutrophil-to-lymphocyte ratio is correlated with response to neoadjuvant chemotherapy as an independent prognostic indicator in breast cancer patients: a retrospective study
BMC Cancer. 2016;16(1):   Crossref logo
Link1 Link2 Link3 Link4

Blood neutrophil–lymphocyte ratio predicts survival in locally advanced cancer stomach treated with neoadjuvant chemotherapy FOLFOX 4
Medical Oncology. 2014;31(12):   Crossref logo
Link1 Link2 Link3

Neutrophil-to-lymphocyte ratio as a prognostic factor in advanced stage ovarian carcinoma treated with neoadjuvant chemotherapy
Gynecologic Oncology. 2019;154:269-270   Crossref logo
Link1 Link2

Neutrophil‐to‐lymphocyte ratio as a prognostic factor in advanced stage ovarian carcinoma treated with neoadjuvant chemotherapy
International Journal of Gynecology & Obstetrics. 2019;148(1):102-106   Crossref logo
Link1 Link2 Link3

Pretreatment hematologic markers as prognostic factors in patients with nasopharyngeal carcinoma: Neutrophil-lymphocyte ratio and platelet-lymphocyte ratio
Head & Neck. 2015;38(S1):E1332-E1340   Crossref logo
Link1 Link2 Link3

The prognostic value of neutrophil–lymphocyte ratio is superior to derived neutrophil–lymphocyte ratio in advanced gastric cancer treated with preoperative chemotherapy and sequential R0 resection: a 5-year follow-up
OncoTargets and Therapy. 2017;Volume 10:2655-2664   Crossref logo
Link1 Link2